Therapeutic Goods Administration, August 30, 2017
Consumers and health professionals are advised that Australasian Medical and Science Ltd (AMSL), in consultation with the TGA, has issued a hazard alert for Essure. AMSL is also recallingunused stock and withdrawing the device from the Australian market.
Read more of Essure contraceptive device: Hazard Alert
The Washington Post, Published on July 26, 2017 Nobody can say exactly how many women have had Essure implanted since the device went on the market in 2002. Bayer, which is headquartered in Germany, says that more than 750,000 devices have been sold worldwide and that sales “continue to grow.” In recent years, the [US] Food and Drug Administration has received more than 16,000 adverse-event...
Women’s Health Victoria Clearinghouse Connector, June 2017 This Clearinghouse Connector focuses on the experience of unplanned pregnancy in Australia and the resources available for women and health professionals to help navigate the decision making process. Although there is surprisingly little information available about the prevalence of unintended pregnancy in Australia, it has been...
Jean Hailes, Last updated 05 May 2017 Jean Hailes has just released a new patient information booklet: The vulva: irritation, diagnosis & treatment. Contents: What is normal? Causes of vulva irritation Management & treatment Dryness ‘Good bacteria’ versus ‘bad bacteria’ in the vagina Other natural therapies Irritation Diagnosis Secretions or discharge Odour...